United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. naproxen tablets are also indicated: - for the relief of the signs and symptoms of tendonitis - for the relief of the signs and symptoms of bursitis - for the relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets are contraindicate

Ireland - English - HPRA (Health Products Regulatory Authority)

italfarmaco s.p.a. - cholecalciferol - oral solution - 25 000 iu international unit(s)/millilitre - vitamin d and analogues; colecalciferol - vitamin d3 and analogues, cholecalciferol - • prophylaxis of rickets and osteomalacia in children and adults • prophylaxis of rickets in preterm newborns • prophylaxis of vitamin d deficiency in children and adults with an identified risk • prophylaxis of vitamin d deficiency in children and adults with malabsorption • treatment of rickets and osteomalacia in children and adults

Ireland - English - HPRA (Health Products Regulatory Authority)

italfarmaco s.p.a. - cholecalciferol - oral drops, solution - 10 000 international unit(s)/millilitre - vitamin d and analogues; colecalciferol - vitamin d3 and analogues, cholecalciferol -
prophylaxis of rickets and osteomalacia in children and adults
prophylaxis of rickets in preterm newborns
prophylaxis of vitamin d deficiency in children and adults with an identified risk
prophylaxis of vitamin d deficiency in children and adults with malabsorption
treatment of rickets and osteomalacia in children and adults

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol - oral solution - 50,000 international unit(s) - vitamin d and analogues; colecalciferol - vitamin d, colecalciferol - for the treatment of vitamin d deficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - colecalciferol - oral solution - 25,000 international unit(s) - vitamin d and analogues; colecalciferol - vitamin d, colecalciferol - the prevention and treatment of vitamin d deficiency. as an adjunct to specific therapy for osteoporosis in patients with vitamin d deficiency or at risk of vitamin d insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol - capsule, soft - 1000 international unit(s) - vitamin d and analogues; colecalciferol

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol - capsule, soft - 7000 international unit(s) - vitamin d and analogues; colecalciferol

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol (02) - capsule, soft - 25,000 international unit(s) - vitamin d and analogues; colecalciferol

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol (02) - capsule, soft - 50,000 international unit(s) - vitamin d and analogues; colecalciferol

Ireland - English - HPRA (Health Products Regulatory Authority)

consilient health limited - cholecalciferol - capsule, soft - 400 international unit(s) - vitamin d and analogues; colecalciferol